...
首页> 外文期刊>Clinical journal of the American Society of Nephrology: CJASN >Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infection
【24h】

Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infection

机译:决定接受来自供体的肾脏的决定性因素,以增加血液传播病毒感染的风险

获取原文
获取原文并翻译 | 示例
           

摘要

Background and objectives: The use of kidneys from donors at increased risk for viral infections (DIRVI) such as HIV could increase the number of transplants and decrease waiting times. This study aimed to identify the proportion of kidney transplant candidates that would accept a kidney from a DIRVI and the factors that influenced this decision. Design, setting, participants, & measurements: Conjoint analysis was used to assess the conditions in which renal transplant candidates would accept a DIRVI kidney. Candidates completed 12 scenarios in which the waiting time for a kidney, the donor age as a surrogate for kidney quality, and the risk of contracting HIV were systematically varied. Results: Among 175 respondents, 42 (24.0%) rejected DIRVI kidneys under all conditions, 103 (58.9%) accepted DIRVI kidneys under some conditions, and 31 (17.7%) always accepted DIRVI kidneys. In multivariable logistic regression, patients were more likely to accept a DIRVI kidney when waiting time was longer, the donor was younger, and HIV risk was lower (P < 0.01 for each variable). Patients on dialysis (P < 0.01) and older patients (P = 0.04) more commonly accepted DIRVI kidneys, but self-rated sense of health was not associated with DIRVI kidney acceptance. Conclusions: Most renal transplant candidates would accept a DIRVI kidney under some circumstances. These findings suggest that recipients can be allowed to make prospective choices regarding DIRVI kidney acceptance without hindering placement of these organs.
机译:背景与目的:使用来自艾滋病毒等病毒感染(DIRVI)风险较高的捐赠者的肾脏可以增加移植次数并减少等待时间。这项研究旨在确定接受DIRVI接受肾脏移植的肾脏移植对象的比例以及影响这一决定的因素。设计,设置,参与者和测量:联合分析用于评估候选肾移植患者接受DIRVI肾脏的条件。候选人完成了12种情况,系统地改变了肾脏的等待时间,作为肾脏质量指标的供体年龄和感染艾滋病毒的风险。结果:在175位受访者中,有42位(24.0%)在所有情况下均拒绝接受DIRVI肾脏,有103位(58.9%)在某些情况下接受了DIRVI肾脏,有31位(17.7%)始终接受了DIRVI肾脏。在多变量logistic回归分析中,等待时间较长,供体较年轻且HIV感染风险较低时,患者更有可能接受DIRVI肾脏治疗(每个变量的P <0.01)。透析患者(P <0.01)和老年患者(P = 0.04)更普遍接受DIRVI肾脏,但自我评价的健康感与DIRVI肾脏接受率无关。结论:大多数肾脏移植候选者在某些情况下会接受DIRVI肾脏。这些发现表明,可以允许接受者对DIRVI肾脏的接受做出前瞻性选择,而不会妨碍这些器官的放置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号